Fronting the twin challenges: Alzheimer’s and Parkinson’s disease

Alzheimer’s and Parkinson’s diseases are two of the most prominent and complex progressive neurological disorders that have a profound global impact. These diseases affect millions of individuals worldwide, causing significant morbidity and placing a substantial burden on healthcare systems and society. Despite considerable advancements in understanding these disorders over the years, developing effective treatments remains a complex and multifaceted challenge.